Position in TAK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,308,287
-$629,522 QoQ
Shares Held
143,998
-9.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#69
of 376 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $43,412,538 across 29 Drug Manufacturers - Specialty & Generic names. TAK ranks #7 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
121,151 | $8,705,910 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
45,360 | $7,644,974 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,855 | $5,339,734 | |
| 4 | VTRS |
Viatris Inc
|
197,717 | $3,139,745 | |
| 5 | HLN |
Haleon plc
|
263,202 | $2,455,674 | |
| 6 | HROW |
Harrow, Inc.
|
56,414 | $2,395,902 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
143,998 | $2,308,287 | |
| 8 | ALKS |
Alkermes plc.
|
42,278 | $2,215,367 |
All Filings in TAK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,308,287 | 143,998 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,937,809 | 158,629 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,851,686 | 118,774 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $601,762 | 41,104 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $594,282 | 38,440 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $539,052 | 36,251 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $230,826 | 17,434 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $343,213 | 24,136 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $337,759 | 26,102 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $529,236 | 38,102 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $803,786 | 56,327 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $919,119 | 59,413 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $511,580 | 32,564 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $517,884 | 31,425 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $569,883 | 36,531 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $206,975 | 15,958 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $174,166 | 12,405 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $120,774 | 8,434 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $212,641 | 15,601 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $126,453 | 7,720 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $148,171 | 8,804 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $148,033 | 8,107 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $111,420 | 6,122 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $74,999 | 4,204 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $54,722 | 3,052 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||